glp-1 ra medications Receptor Agonists: The New Wave in Diabetes Management GLP-1 Drug Comparison in Diabetes

This gives Mounjaro a slight advantage in achieving faster weight-loss results. In a head-to-head clinical trial, Lilly reported that tirzepatide led to an average weight reduction of 20.2%, compared to 13.7% with semaglutide after 72 weeks of treatmenta 47% greater relative weight loss with tirzepatide

4 Clinical evidence in T2DM management A wide range of clinical trials and research have been performed to assess the effectiveness, safety, and tolerability of short-acting against long-acting GLP-1 analogues in the treatment and management of T2DM and obesity

This study shows that as new medications are approved we need to be careful as long term side-effects may be seen that we were not aware of. Diabetes is very common in our practices and many of our patients are put on the GPL-1s, Geffen continued

[DOI] [PMC free article] [PubMed] [Google Scholar] Efron D., Jarman F., Barker M., Dip G., Psych E

However, berberine did improve sugar and cholesterol

B., Linetzky, B., Davies, M